Eric Hsi, M.D.
| Appointed: |
1997 |
| Gender: |
Male |
| Languages: |
English |
Clinical Pathology
Section Head, Hematopathology
Pathology and Laboratory Medicine Institute
Anatomic Pathology
Biographical Sketch
Eric Hsi, MD, is the Section Head of Hematopathology and Medical Director of the automated hematology, flow cytometry, and immunohistochemistry laboratories in the Institute of Pathology and Laboratory Medicine.
He received his medical training and post-graduate training in pathology and hematopathology at the University of Michigan and is board-certified in anatomic pathology, clinical pathology, and hematopathology. His clinical interests involve leukemia and lymphoma diagnosis, immunophenotyping and molecular diagnostics related to these disorders. Dr. Hsi's research interests include diagnostic and biologic prognostic markers in hematologic malignancy, as well as development of new therapeutics. He currently conducts research sponsored by various government and industry sources.
Dr. Hsi is a recognized expert in lymphoma diagnosis and is the Lymphoma Pathology Cadre Leader for the Cancer and Leukemia Group B. He has published more than 120 peer-reviewed articles and numerous book chapters and is the editor of a hematopathology text book. He regularly participates as faculty in post-graduate educational courses at national meetings, serves on committees for the American Society of Clinical Pathology and College of American Pathologists, and serves on the editorial board of several journals.
Professional Highlights
- Cancer and Leukemia Group B - Lymphoma Pathology Cadre Leader
- Editorial Board Member: American Journal of Clinical Pathology, Human Pathology, Diagnostic Molecular Pathology, Archives of Pathology and Laboratory Medicine
Education & Fellowships
| Medical School: | University of Michigan Medical School, Ann Arbor, MI |
|
| Internship: | University of Michigan Health System, Pathology, Ann Arbor, MI |
| Residency: | University of Michigan Health System, Pathology, Ann Arbor, MI |
| Fellowship: | University of Michigan Health System, Surgical Pathology, Ann Arbor, MI |
| Other Education: | (Undergraduate) Kalamazoo College, Kalamazoo, MI |
Certifications
Hematology
Anatomic & Clinical Pathology
Specialty Interests
Hematopathology, immunophenotyping, molecular diagnostics.
Awards & Honors
NIH R21 CA123006 Characterization of Methods for Preservation of Phosphoproteins in Fixed Tissues, Principal Investigator
Professional Memberships
- United States and Canadian Academy of Pathology
- Society for Hematopathology
- American Society of Hematology
- College of American Pathologists
- American Society of Clinical Pathology
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/2/2008, Dr. Hsi has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Hsi receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
